Palatin to Report Fourth Quarter and Fiscal Year End 2024 Results
Palatin Technologies, Inc. (NYSE American: PTN) will announce its fourth quarter and fiscal year end 2024 operating results on Tuesday, October 1, 2024, before the U.S. financial markets open.
Rhea-AI Summary
Palatin Technologies, Inc. (NYSE American: PTN) will announce its fourth quarter and fiscal year end 2024 operating results on Tuesday, October 1, 2024, before the U.S. financial markets open. The company will host a conference call and live audio webcast at 11:00 AM Eastern Time on the same day, featuring a review of operating results and updates on programs under development.
The press release will be available at 7:30 a.m. ET, followed by the live conference call at 11:00 a.m. ET. A replay of the call will be accessible from October 1 to October 15, 2024. Investors can access the webcast through Palatin's website.
Palatin is a biopharmaceutical company focusing on first-in-class medicines based on melanocortin receptor systems for treating diseases with significant unmet medical needs.
Positive
- Timely reporting of quarterly and annual financial results
- Providing investor access through conference call and webcast
- Focus on first-in-class medicines for unmet medical needs
Negative
- None.
Details
News Market Reaction – PTN
The recorded move for PTN in the trading session of this news was -1.39%.
Data tracked by StockTitan Argus. Session date unavailable.
AI-generated analysis. How Rhea-AI works. Not financial advice.
Teleconference and Webcast to be held on October 1, 2024
Palatin will also conduct a conference call and live audio webcast hosted by its executive management team on October 1, 2024 at 11:00 AM Eastern Time. The conference call will include a review of the company's operating results and an update on programs under development.
Schedule for the Operating Results Press Release, Conference Call / Audio Webcast
Q4 & Fiscal Year End 2024 Results Press Release | 10/01/2024 at 7:30 a.m. ET |
Q4 & Fiscal Year End 2024 Conference Call-Live | 10/01/2024 at 11:00 a.m. ET |
US Toll Free Dial-In Number: | 1-888-506-0062 |
International Dial-In Number: | 1-973-528-0011 |
Participant Access Code: | 252326 |
Q4 & Fiscal Year End 2024 Conference Call-Replay | 10/01/2024-10/15/2024 |
US Toll Free Dial-In Number: | 1-877-481-4010 |
International Dial-In Number: | 1-919-882-2331 |
Participant Access Code: | 51290 |
The audio webcast and replay can be accessed by logging on to the "Investors-Webcasts" section of Palatin's website at http://www.palatin.com or by clicking here.
About Palatin
Palatin is a biopharmaceutical company developing first-in-class medicines based on molecules that modulate the activity of the melanocortin receptor systems, with targeted, receptor-specific product candidates for the treatment of diseases with significant unmet medical need and commercial potential. Palatin's strategy is to develop products and then form marketing collaborations with industry leaders to maximize their commercial potential. For additional information regarding Palatin, please visit Palatin's website at www.palatin.com and follow Palatin on Twitter at @PalatinTech.
View original content to download multimedia:https://www.prnewswire.com/news-releases/palatin-to-report-fourth-quarter-and-fiscal-year-end-2024-results-302259586.html
SOURCE Palatin Technologies, Inc.
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.